Skip to main content
. Author manuscript; available in PMC: 2013 Jun 19.
Published in final edited form as: Arch Neurol. 2010 Nov;67(11):1316–1322. doi: 10.1001/archneurol.2010.275

Table 1.

Epigenetic Regulatory Mechanisms in Stroke

Epigenetic Mechanisms Description Relevance to Stroke
DNA methylation Refers to the transfer of methyl groups from SAM to cytosine residues in various genomic regions Levels are increased in the ischemic brain and may be responsible for promoting neural cell death
Mediated by DNA methyltransferase enzymes Deficiency of methylenetetrahydrofolate reductase, which is involved in the formation of SAM, causes hyperhomocysteinemia and an increased risk of stroke
Regulates gene expression as well as diverse cellular processes, including maintenance of genomic stability, XCI, and genomic imprinting Extent of XCI in female heterozygotes with Fabry disease determines clinical involvement, including risk of stroke
Imprinted GNAS genomic locus is important for glucose and lipid metabolism and platelet function
Abnormal DNA methylation is associated with atherosclerosis, obesity, insulin resistance, kidney disease, cancer, and autoimmunity
Histone code modifications, nucleosome remodeling, and higher-order chromatin formation Refer to highly integrated epigenetic mechanisms that modulate chromatin structure and function at single nucleotides (histone code modification), specific gene loci (nucleosome remodeling), and more extensive genomic regions (higher-order chromatin formation) Histone acetylation levels are perturbed in the ischemic brain and may be associated with mediating neural cell death and protective responses, including excitotoxicity, oxidative stress, inflammation, cell cycle regulation, DNA repair, and apoptosis
Mediated by histone-, nucleosome-, and chromatin-modifying enzymes that are often components of large, multifunctional epigenetic macromolecular complexes Abnormal chromatin is a key feature of necrotic cell death and apoptotic cell death, which are both associated with neural injury in stroke
Play vital roles in executing genomic programs such as gene activation and silencing Schimke immunoosseous dysplasia is a disease characterized by increased risk of stroke, which is caused by mutation of a nucleosome remodeling enzyme (ie, SMARCAL1)
Antichromatin and antihistone antibodies are found in systemic lupus erythematosus, which is associated with an increased risk of stroke due to multiple factors
Chromatin dynamics are important for modulating cholesterol synthesis, transport, and metabolic pathways

Abbreviations: SAM, S-adenosylmethionine; SMARCAL1, SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A-like 1; XCI, X chromosome inactivation.